The global peptide therapeutics CDMO market stands at the threshold of a decade-long expansion trajectory that promises to reshape pharmaceutical contract manufacturing infrastructure and advanced peptide synthesis systems. According to a recent industry report by Fact.MR, the market is projected to surge from USD 2.9 billion in 2025 to USD 8.1 billion by 2035, expanding at a robust...